Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Kyowa Kirin Co., Ltd.
An exploratory study to investigate the effects of RTA 402 on glomerular filtration rate in CKD patients with type 2 diabetes mellitus.
To evaluate the safety of RTA 402.
Age
20–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
CKD patients with type 2 diabetes mellitus
Patients whose eGFR levels are eligible for this study
Patients being treated with stable dose of ACE inhibitors and/or ARB etc.
You may not be if
Patients with Type 1 diabetes
Patients with known non-diabetic renal disease
Patients with a history of renal transplantation
Patients with mean SBP \> 160 mmHg or mean DBP \> 90 mmHg
Patients with HbA1C \> 10%
Patients with cardiovascular disease specified in the study protocol
Patients for whom Inulead® injection is contraindicated etc.
